Trials / Completed
CompletedNCT06140745
Evaluation of Dentifrice Formulations to Remineralize Enamel and Dentine Subsurface Lesions in a Double-Blind In-Situ Clinical Trial
Evaluation of Efficacy of Experimental Dentifrice Formulations With Different Forms of Fluoride and/or Other Agents to Remineralize Enamel and Dentine Subsurface Lesions in a Double-Blind Randomized In-Situ Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Procter and Gamble · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
To compare the remineralization and demineralization inhibition potential of early subsurface carious lesions in enamel in situ after rinsing with five different aqueous slurries of toothpaste formulations. Percent remineralization (%R), i.e. the % change in ΔZ values relative to ΔZd, will be the primary outcome measure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0 ppm Fluoride Dentifrice 1 | Each subject will use this product during one of the five treatment periods in the crossover study design. |
| DRUG | 1100 ppm NaF Fluoride Dentifrice | Each subject will use this product during one of the five treatment periods in the crossover study design. |
| DRUG | 1500 ppm NaMFP Fluoride Dentifrice | Each subject will use this product during one of the five treatment periods in the crossover study design. |
| DRUG | 0 ppm Fluoride Dentifrice 2 | Each subject will use this product during one of the five treatment periods in the crossover study design. |
| DRUG | 0 ppm Fluoride Dentifrice 3 | Each subject will use this product during one of the five treatment periods in the crossover study design. |
Timeline
- Start date
- 2020-10-05
- Primary completion
- 2021-02-21
- Completion
- 2021-02-21
- First posted
- 2023-11-20
- Last updated
- 2023-11-20
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT06140745. Inclusion in this directory is not an endorsement.